en Experimental Neurobiology

Cited by CrossRef (37)

  1. Wei Liu, Alon Rabinovich, Yuval Nash, Dan Frenkel, Yuqiang Wang, Moussa B.H. Youdim, Orly Weinreb. Anti-inflammatory and protective effects of MT-031, a novel multitarget MAO-A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells. Neuropharmacology 2017;113:445
    https://doi.org/10.1016/j.neuropharm.2016.10.028
  2. Liudmila Efremova, Stefan Schildknecht, Martina Adam, Regina Pape, Simon Gutbier, Benjamin Hanf, Alexander Bürkle, Marcel Leist. Prevention of the degeneration of human dopaminergic neurons in an astrocyte co‐culture system allowing endogenous drug metabolism. British J Pharmacology 2015;172:4119
    https://doi.org/10.1111/bph.13193
  3. Haotian Liu, Yong Xie, Xia Wang, Martine I. Abboud, Chao Ma, Wei Ge, Christopher J. Schofield. Exploring links between 2‐oxoglutarate‐dependent oxygenases and Alzheimer's disease. Alzheimer's & Dementia 2022;18:2637
    https://doi.org/10.1002/alz.12733
  4. Akhil Kumar, Ashok Sharma. Computational Modeling of Drugs Against Alzheimer’s Disease. 2022.
    https://doi.org/10.1007/978-1-4939-7404-7_19
  5. Ahmed Elkamhawy, Hyeon Jeong Kim, Mohamed H. Elsherbeny, Sora Paik, Jong-Hyun Park, Lizaveta Gotina, Magda H. Abdellattif, Noha A. Gouda, Jungsook Cho, Kyeong Lee, Ae Nim Pae, Ki Duk Park, Eun Joo Roh. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action. Bioorganic Chemistry 2021;116:105352
    https://doi.org/10.1016/j.bioorg.2021.105352
  6. V. B. Sokolov, A. Yu. Aksinenko, T. V. Goreva, T. A. Epishina, V. V. Grigor´ev, A. V. Gabrel´yan, D. V. Vinogradova, M. E. Neganova, E. F. Shevtsova, S. O. Bachurin. Molecular design of multitarget neuroprotectors 3. Synthesis and bioactivity of tetrahydrocarbazole—aminoadamantane conjugates. Russ Chem Bull 2016;65:1354
    https://doi.org/10.1007/s11172-016-1461-5
  7. Andrii Domanskyi, Heike Alter, Miriam A. Vogt, Peter Gass, Ilya A. Vinnikov. Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance. Front. Cell. Neurosci. 2014;8
    https://doi.org/10.3389/fncel.2014.00275
  8. Joana Reis, Fernando Cagide, Martín Estrada Valencia, José Teixeira, Donatella Bagetta, Concepción Pérez, Eugenio Uriarte, Paulo J. Oliveira, Francesco Ortuso, Stefano Alcaro, María Isabel Rodríguez-Franco, Fernanda Borges. Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors. European Journal of Medicinal Chemistry 2018;158:781
    https://doi.org/10.1016/j.ejmech.2018.07.056
  9. Andrew Waye, Malar Annal, Andrew Tang, Gabriel Picard, Frédéric Harnois, José A. Guerrero-Analco, Ammar Saleem, L. Mark Hewitt, Craig B. Milestone, Deborah L. MacLatchy, Vance L. Trudeau, John T. Arnason. Canadian boreal pulp and paper feedstocks contain neuroactive substances that interact in vitro with GABA and dopaminergic systems in the brain. Science of The Total Environment 2014;468-469:315
    https://doi.org/10.1016/j.scitotenv.2013.08.040
  10. Neha Atulkumar Singh, Abul Kalam Azad Mandal, Zaved Ahmed Khan. Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG). Nutr J 2015;15
    https://doi.org/10.1186/s12937-016-0179-4
  11. Veda Prachayasittikul, Ratchanok Pingaew, Supaluk Prachayasittikul, Virapong Prachayasittikul. 8-Hydroxyquinolines: A Promising Pharmacophore Potentially Developed as Disease-Modifying Agents for Neurodegenerative Diseases: A Review. HETEROCYCLES 2022;105:202
    https://doi.org/10.3987/REV-22-SR(R)6
  12. Rabea Basri, Faryal Mehwish Awan, Burton B. Yang, Usman Ayub Awan, Ayesha Obaid, Anam Naz, Aqsa Ikram, Suliman Khan, Ijaz ul Haq, Sadiq Noor Khan, Muslim Bin Aqeel. Brain-protective mechanisms of autophagy associated circRNAs: Kick starting self-cleaning mode in brain cells via circRNAs as a potential therapeutic approach for neurodegenerative diseases. Front. Mol. Neurosci. 2023;15
    https://doi.org/10.3389/fnmol.2022.1078441
  13. Meihui Chen, Anmin Liu, Ying Ouyang, Yingjuan Huang, Xiaojuan Chao, Rongbiao Pi. Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?. Expert Opinion on Investigational Drugs 2013;22:537
    https://doi.org/10.1517/13543784.2013.778242
  14. Siew L. Cheong, Stephanie Federico, Giampiero Spalluto, Karl-Norbert Klotz, Giorgia Pastorin. The current status of pharmacotherapy for the treatment of Parkinson’s disease: transition from single-target to multitarget therapy. Drug Discovery Today 2019;24:1769
    https://doi.org/10.1016/j.drudis.2019.05.003
  15. Ritu Prajapati, Su Hui Seong, Pradeep Paudel, Se Eun Park, Hyun Ah Jung, Jae Sue Choi. In Vitro and In Silico Characterization of Kurarinone as a Dopamine D1A Receptor Antagonist and D2L and D4 Receptor Agonist. ACS Omega 2021;6:33443
    https://doi.org/10.1021/acsomega.1c04109
  16. Jeffrey S. Derrick, Mi Hee Lim. Tools of the Trade: Investigations into Design Strategies of Small Molecules to Target Components in Alzheimer's Disease. ChemBioChem 2015;16:887
    https://doi.org/10.1002/cbic.201402718
  17. S. O. Bachurin, V. B. Sokolov, A. Yu. Aksinenko, T. A. Epishina, T. V. Goreva, A. V. Gabrel´yan, V. V. Grigor´ev. Molecular construction of multitarget neuroprotectors 1. Synthesis and biological activity of conjugates of substituted indoles and bis(dimethylamino)phenothiazine. Russ Chem Bull 2015;64:1354
    https://doi.org/10.1007/s11172-015-1017-0
  18. V. B. Sokolov, A. Yu. Aksinenko, T. V. Goreva, T. A. Epishina, V. V. Grigor´ev, A. V. Gabrel´yan, D. V. Vinogradova, L. G. Dubova, P. N. Shevtsov, E. F. Shevtsova, S. O. Bachurin. Molecular design of multitarget neuroprotectors 2. Synthesis and bioactivity of carbazole—γ-carboline conjugates. Russ Chem Bull 2016;65:1346
    https://doi.org/10.1007/s11172-016-1460-6
  19. Maria João Matos, Fernanda Rodríguez-Enríquez, Santiago Vilar, Lourdes Santana, Eugenio Uriarte, George Hripcsak, Martín Estrada, María Isabel Rodríguez-Franco, Dolores Viña. Potent and selective MAO-B inhibitory activity: Amino- versus nitro-3-arylcoumarin derivatives. Bioorganic & Medicinal Chemistry Letters 2015;25:642
    https://doi.org/10.1016/j.bmcl.2014.12.001
  20. Galina F. Makhaeva, Sofya V. Lushchekina, Natalia P. Boltneva, Vladimir B. Sokolov, Vladimir V. Grigoriev, Olga G. Serebryakova, Ekaterina A. Vikhareva, Alexey Yu. Aksinenko, George E. Barreto, Gjumrakch Aliev, Sergey O. Bachurin. Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease. Sci Rep 2015;5
    https://doi.org/10.1038/srep13164
  21. Meng Zhang, Zhigang Bian. The Emerging Role of Circular RNAs in Alzheimer’s Disease and Parkinson’s Disease. Front. Aging Neurosci. 2021;13
    https://doi.org/10.3389/fnagi.2021.691512
  22. Joana Reis, Fernando Cagide, Daniel Chavarria, Tiago Silva, Carlos Fernandes, Alexandra Gaspar, Eugenio Uriarte, Fernando Remião, Stefano Alcaro, Francesco Ortuso, Fernanda Borges. Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors. J. Med. Chem. 2016;59:5879
    https://doi.org/10.1021/acs.jmedchem.6b00527
  23. Hayrettin O. Gülcan, Ilkay E. Orhan. The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer’s Disease and Parkinson Disease. CPD 2020;26:509
    https://doi.org/10.2174/1381612826666200131103524
  24. Claudio Giuliano, Silvia Cerri, Valentina Cesaroni, Fabio Blandini. Relevance of Biochemical Deep Phenotyping for a Personalised Approach to Parkinson’s Disease. Neuroscience 2023;511:100
    https://doi.org/10.1016/j.neuroscience.2022.12.019
  25. Lorena Ortega Moreno, Ana Bagues, Vicente Martínez, Raquel Abalo. New Pieces for an Old Puzzle: Approaching Parkinson’s Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics. Nutrients 2023;15:2775
    https://doi.org/10.3390/nu15122775
  26. Gizella Csire, Laetitia Canabady-Rochelle, Marie-Christine Averlant-Petit, Katalin Selmeczi, Loic Stefan. Both metal-chelating and free radical-scavenging synthetic pentapeptides as efficient inhibitors of reactive oxygen species generation. 2020;12:1220
    https://doi.org/10.1039/d0mt00103a
  27. V. B. Sokolov, G. F. Makhaeva, A. Yu. Aksinenko, V. V. Grigoriev, E. F. Shevtsova, S. O. Bachurin. Targeted synthesis and biological activity of polypharmacophoric agents for the treatment of neurodegenerative diseases. Russ Chem Bull 2017;66:1821
    https://doi.org/10.1007/s11172-017-1953-y
  28. Maria J. Matos, Santiago Vilar, Rosa Mª Gonzalez-Franco, Eugenio Uriarte, Lourdes Santana, Carol Friedman, Nicholas P. Tatonetti, Dolores Viña, Jose A. Fontenla. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study. European Journal of Medicinal Chemistry 2013;63:151
    https://doi.org/10.1016/j.ejmech.2013.02.009
  29. Valentina Oliveri, Graziella Vecchio. 8-Hydroxyquinolines in medicinal chemistry: A structural perspective. European Journal of Medicinal Chemistry 2016;120:252
    https://doi.org/10.1016/j.ejmech.2016.05.007
  30. V. B. Sokolov, A. Yu. Aksinenko, T. A. Epishina, T. V. Goreva, V. V. Grigoriev, A. V. Gabrel´yan, S. O. Bachurin. Synthesis and biological activity of N-substituted tetrahydro-γ-carbolins bearing bis(dimethylamino)phenothiazine moiety. Russ Chem Bull 2015;64:718
    https://doi.org/10.1007/s11172-015-0925-3
  31. David G. Workman, Andrew Tsatsanis, Frank W. Lewis, John P. Boyle, Maryam Mousadoust, Nishani T. Hettiarachchi, Michael Hunter, Chris S. Peers, David Tétard, James A. Duce. Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators. Metallomics 2015;7:867
    https://doi.org/10.1039/C4MT00326H
  32. Flávia Pereira Dias Viegas, Matheus de Freitas Silva, Miguel Divino da Rocha, Maísa Rosa Castelli, Mariana Máximo Riquiel, Rafael Pereira Machado, Sarah Macedo Vaz, Laís Medeiros Simões de Lima, Karla Cristine Mancini, Patrícia Cruz Marques de Oliveira, Élida Parreira Morais, Vanessa Silva Gontijo, Fernanda Motta R. da Silva, Dora D'Alincourt da Fonseca Peçanha, Newton Gonçalves Castro, Gilda A. Neves, Alexandre Giusti-Paiva, Fabiana Cardoso Vilela, Lidiane Orlandi, Ihosvany Camps, Márcia Paranho Veloso, Luis Felipe Leomil Coelho, Marisa Ionta, Guilherme Álvaro Ferreira-Silva, Rodrigo Machado Pereira, Laurent E. Dardenne, Isabella Alvim Guedes, Wellerson de Oliveira Carneiro Junior, Paula Maria Quaglio Bellozi, Antônio Carlos Pinheiro de Oliveira, Fábio Furlan Ferreira, Letizia Pruccoli, Andrea Tarozzi, Claudio Viegas. Design, synthesis and pharmacological evaluation of N -benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates. European Journal of Medicinal Chemistry 2018;147:48
    https://doi.org/10.1016/j.ejmech.2018.01.066
  33. Ahmed Elkamhawy, Jiyu Woo, Noha A. Gouda, Jushin Kim, Hossam Nada, Eun Joo Roh, Ki Duk Park, Jungsook Cho, Kyeong Lee. Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress. Antioxidants 2021;10:1604
    https://doi.org/10.3390/antiox10101604
  34. Seok Yong Kang, Hyo Won Jung, Mi-Young Lee, Hye Won Lee, Seong Wook Chae, Yong-Ki Park. Effect of the semen extract of Cuscuta chinensis on inflammatory responses in LPS-stimulated BV-2 microglia. Chinese Journal of Natural Medicines 2014;12:573
    https://doi.org/10.1016/S1875-5364(14)60088-1
  35. Frank W. Lewis, David Tétard. Biometals in Neurodegenerative Diseases. 2014.
    https://doi.org/10.1016/B978-0-12-804562-6.00020-8
  36. Wei Liu, Ming Lang, Moussa B.H. Youdim, Tamar Amit, Yewei Sun, Zaijun Zhang, Yuqiang Wang, Orly Weinreb. Design, synthesis and evaluation of novel dual monoamine-cholinesterase inhibitors as potential treatment for Alzheimer’s disease. Neuropharmacology 2016;109:376
    https://doi.org/10.1016/j.neuropharm.2016.06.013
  37. Anna R. Carta, Augusta Pisanu. Modulating Microglia Activity with PPAR-γ Agonists: A Promising Therapy for Parkinson’s Disease?. Neurotox Res 2013;23:112
    https://doi.org/10.1007/s12640-012-9342-7